Risedronic Acid

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

41 API Suppliers, 17 USDMF, 8 CEP/COS, 6 JDMF, 11 EU WC, 26 KDMF, 9 NDC API, 26 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

7 Intermediates Suppliers

7 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

230 FDF Dossiers, 38 FDA Orange Book, 143 Europe, 4 Canada, 23 Australia, 5 South Africa, 17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 150MG, TABLET;ORAL - 30MG, TABLET;ORAL - 35MG, TABLET;ORAL - 5MG, TABLET;ORAL - 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - 35MG